Co-Diagnostics 宣布 2026 年第三季度财报发布日期及网络直播
Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast
Co-Diagnostics（Nasdaq: CODX）将于 2026 年 11 月 12 日美股收盘后发布 2026 年第三季度财务业绩，并于当日美东时间下午 4:30 举行电话会议和网络直播，与分析师讨论业绩。CEO Dwight Egan 与财务及会计执行副总裁 Daniel Bohrer 将出席，直播回放后续在公司官网提供。
, /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will release its third quarter 2026 financial results on Thursday, November 12, 2026, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer and Daniel Bohrer, Executive Vice President of Finance and Accounting.
The conference call and webcast will be available via:
Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here
Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.
SOURCE Co-Diagnostics
来源：PR Newswire Health · prnewswire.com